New York-based Jones just raised $10 million to expand its nicotine lozenge company in the stodgy, $3 billion smoking cessation market.

Haleon PLC closed 6.66% short of its 52-week high of £4.18, which the company reached on March 4th.

Commonwealth Equity Services LLC lessened its holdings in shares of Haleon plc (NYSE:HLN – Free Report) by 3.3% in the fourth ...

Haleon offers plenty of stability amidst the current market volatility, with its Power Brands driving strong organic growth.

Haleon PLC HLN shares slid 1.91% to £3.86 Monday, on what proved to be an all-around poor trading session for the stock ...

Haleon has named Nathalie Gerschtein as president North America, following Lisa Paley’s announcement to step down from her ...

AstraZeneca signed a deal with Alteogen worth up to $1.35 billion for subcutaneous cancer drugs. Taiho Pharmacetical bought ...

Avantax Advisory Services Inc. cut its position in shares of Haleon plc (NYSE:HLN – Free Report) by 17.2% during the fourth ...

Gerschtein is pivoting to the consumer health space after nearly 23 years in beauty at L'Oréal serving a variety of brands ...

This week, the FDA approved J&J’s JNJ Tremfya for its second inflammatory bowel disease (“IBD”) condition, Crohn’s disease ...

Pfizer has officially kissed goodbye to its consumer health venture by selling its final 7.3% stake in Haleon for a tidy $3.3 ...

A roundup of the latest health news includes Yemen's malnutrition crisis, potential CDC leadership changes, the role of ...